NEURONANO

Do nanoparticles induce neurodegenerative diseases? Understanding the origin of reactive oxidative species and protein aggregation and mis-folding phenomena in the presence of nanoparticles

 Coordinatore UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN 

 Organization address address: BELFIELD
city: DUBLIN
postcode: 4

contact info
Titolo: Mr.
Nome: Donal
Cognome: Doolan
Email: send email
Telefono: 35317161656
Fax: 35317161216

 Nazionalità Coordinatore Ireland [IE]
 Sito del progetto http://www.neuronano.eu
 Totale costo 4˙823˙050 €
 EC contributo 2˙498˙000 €
 Programma FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies
 Code Call FP7-NMP-2007-SMALL-1
 Funding Scheme CP-FP
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-02-01   -   2012-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

 Organization address address: BELFIELD
city: DUBLIN
postcode: 4

contact info
Titolo: Mr.
Nome: Donal
Cognome: Doolan
Email: send email
Telefono: 35317161656
Fax: 35317161216

IE (DUBLIN) coordinator 884˙061.75
2    UNIVERSITY OF ULSTER

 Organization address address: CROMORE ROAD
city: COLERAINE
postcode: BT52 1SA

contact info
Titolo: Dr.
Nome: Anne Marie
Cognome: Patton
Email: send email
Telefono: +44 28 7032 3383
Fax: +44 2870 32 4922

UK (COLERAINE) participant 420˙617.00
3    JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION

 Organization address address: Rue de la Loi 200
city: BRUSSELS
postcode: 1049

contact info
Titolo: Mr.
Nome: Raymond
Cognome: Crandon
Email: send email
Telefono: +39 0332 78 9828
Fax: +39 0332 78 9717

BE (BRUSSELS) participant 352˙200.00
4    HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

 Organization address address: Ingolstaedter Landstrasse 1
city: MUENCHEN
postcode: 85764

contact info
Titolo: Dr.
Nome: Juergen
Cognome: Ertel
Email: send email
Telefono: -6249
Fax: -7093

DE (MUENCHEN) participant 337˙500.00
5    THE UNIVERSITY OF EDINBURGH

 Organization address address: OLD COLLEGE, SOUTH BRIDGE
city: EDINBURGH
postcode: EH8 9YL

contact info
Titolo: Ms.
Nome: Angela
Cognome: Noble
Email: send email
Telefono: +44 131 650 9024
Fax: +44 131 650 9023

UK (EDINBURGH) participant 251˙621.25
6    UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK

 Organization address address: Western Road
city: CORK
postcode: -

contact info
Titolo: Prof.
Nome: Pater
Cognome: Kennedy
Email: send email
Telefono: +353 21 4903500
Fax: +353 21 4903506

IE (CORK) participant 167˙000.00
7    UNIVERSIDADE FEDERAL DO CEARA

 Organization address address: AVENIDA DA UNIVERSIDADE 2853
city: FORTALEZA
postcode: 60020181

contact info
Titolo: Dr.
Nome: Francisco Antonio
Cognome: Guimaraes
Email: send email
Telefono: +55 85 3281 3444
Fax: +55 85 3243 5381

BR (FORTALEZA) participant 85˙000.00
8    NATIONAL INSTITUTE FOR MATERIALS SCIENCE

 Organization address address: SENGEN 1-2-1
city: TSUKUBA
postcode: 305 0047

contact info
Titolo: Mr.
Nome: Masahiro
Cognome: Takemura
Email: send email
Telefono: +81 29 859 2402
Fax: +81 29 859 2049

JP (TSUKUBA) participant 0.00
9    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

 Organization address address: "FRANKLIN STREET 1111, 12 FLOOR"
city: OAKLAND CA
postcode: 94607

contact info
Titolo: Ms.
Nome: Evelyn
Cognome: Balabis
Email: send email
Telefono: +1 310 794 2838
Fax: +1 310 794 2852

US (OAKLAND CA) participant 0.00
10    UNIVERSITY OF ROCHESTER

 Organization address address: "ELMWOOD AVENUE, BOX EHSC 601"
city: ROCHESTER NY
postcode: 14642

contact info
Titolo: Dr.
Nome: Jane
Cognome: Tolbert
Email: send email
Telefono: +1 585 275 4210
Fax: +1 585 275 9492

US (ROCHESTER NY) participant 0.00
11    WILLIAM MARSH RICE UNIVERSITY

 Organization address address: MAIN STREET 6100
city: HOUSTON TEXAS
postcode: 77005

contact info
Titolo: Ms.
Nome: Nancy
Cognome: Nisbett
Email: send email
Telefono: +1 713 348 6200
Fax: +1 713 348 5425

US (HOUSTON TEXAS) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

neurodegenerative    critical    fibrillation    species    alzheimer    determine    brain    nanoparticle    blood    determines    nanoparticles    induce    mechanisms    animal    biomolecule    barrier    corona    protein    vivo    biological    diseases    nature    risk   

 Obiettivo del progetto (Objective)

'As the use of nanoparticles becomes more prevalent, it is clear that human exposure will inevitably increase. Considering the rapidly ageing European population and the resulting increase in the incidence of neurodegenerative diseases, there is an urgent need to address the risk presented by nanoparticles towards neurodegenerative diseases. It is believed that nanoparticles can pass through the blood-brain barrier. Once in the brain, nanoparticles have two potential major effects. They can induce oxidative activity (production of Reactive Oxygen Species), and can induce anomalous protein aggregation behaviour (fibrillation). There are multiple disease targets for the nanoparticles, including all of the known fibrillation diseases (e.g. Alzheimer’s and Parkinson’s diseases). The factors that determine which nanoparticles enter the brain are not known. Nanoparticle size, shape, rigidity and composition are considered important, and under physiological conditions, the nature of the adsorbed biomolecule corona (proteins, lipids etc.) determines the biological responses. The NeuroNano project will investigate the detailed mechanisms of nanoparticle passage through the blood-brain barrier using primary cell co-cultures and animal studies. Using nanoparticles that are shown to reach the brain, we will determine the mechanisms of ROS production and protein fibrillation, using state-of-the-art approaches such as redox proteomics and isolation/characterisation of the critical pre-fibrillar species. Animal models for Alzheimer’s diseases will confirm the effects of the nanoparticles in vivo. At all stages the exact nature of the nanoparticle biomolecule corona will be determined. The result will be a risk-assessment framework for assessing the safety of nanoparticles towards neurodegenerative diseases, based on the connection of their biological effects to their biomolecule corona, which determines the biological response in vivo and reports on the nanoparticles’ history.'

Introduzione (Teaser)

Engineered nanoparticles (NPs) are miniature entities of materials also manufactured in bulk but with very different properties. As their prevalence increases, it is critical to evaluate the potential impact on public health.

Altri progetti dello stesso programma (FP7-NMP)

NANOMICEX (2012)

Mitigation of risk and control of exposure in nanotechnology based inks and pigments - NANOMICEX -

Read More  

POLYCAT (2010)

Modern polymer-based catalysts and microflow conditions as key elements of innovations in fine chemical syntheses

Read More  

DIRECTSPARE (2009)

Strengthening the industries’ competitive position by the development of a logistical and technological system for “spare parts” that is based on on-demand production

Read More